MCA
LABU icon

Millennium Capital Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Millennium Capital Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,063
Closed -$648K – 137
2025
Q4 		$648K Buy
4,063
+733
+22% +$101K 0.38% 55
2025
Q3 		$312K Buy
+3,330
New +$235K 0.19% 97

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Millennium Capital Advisors's LABU Position: Q1 2026 in Review

Millennium Capital Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 4,063 shares — an estimated $648K sold.

Millennium Capital Advisors first reported a position in LABU in Q3 2025 and held it in 2 quarters. The position peaked at $648K in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Millennium Capital Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • Millennium Capital Advisors sold 4,063 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $648K.
  • Millennium Capital Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2025 and held it in 2 quarters.
  • Millennium Capital Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $648K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Millennium Capital Advisors's 13F filing for Q1 2026, filed 12 May 2026.